Dec 06, 2022

Current Approaches to the Diagnosis and Management of Amyloidosis

Read more

Nov 28, 2022

Impact of Earlier Diagnosis in Cardiac ATTR Amyloidosis Over the Course of 20 Years

Read more

Nov 23, 2022

Amyloid Nomenclature 2022: Update, Novel Proteins, and Recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee

Read more

Nov 14, 2022

Survival Benefit of Birtamimab in Mayo Stage IV AL Amyloidosis in the Phase 3 VITAL Study Consistent After Adjustment for Key Baseline Variables

Read more

Jul 22, 2022

Efficacy and Safety of Vutrisiran for Patients With Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy: A Randomized Clinical Trial

Read more

Jul 13, 2022

Stem Cell Transplantation Produces Prolonged Survival With Improved Safety in Patients With AL Amyloidosis

Read more

Jun 01, 2022

Guidelines and New Directions in the Therapy and Monitoring of ATTRv Amyloidosis

Read more

May 17, 2022

Sex Differences in Wild-Type Transthyretin Amyloidosis: An Analysis From the Transthyretin Amyloidosis Outcomes Survey (THAOS)

Read more

Mar 22, 2022

RNA-Targeting and Gene Editing Therapies for Transthyretin Amyloidosis

Read more

Mar 16, 2022

How Did Transthyretin Amyloid Cardiomyopathy Progress in Patients Who Took Placebo in the Study ATTR-ACT? A Plain Language Summary

Read more

Subscribe to